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Absence of CCR4 Exacerbates Skin Inflammation in an
Oxazolone-Induced Contact Hypersensitivity Model
Sari Lehtima¨ki1, Sari Tillander1, Anne Puustinen1, Sampsa Matikainen1, Tuula Nyman2, Nanna Fyhrquist1,
Terhi Savinko1, Marja-Leena Majuri1, Henrik Wolff3, Harri Alenius1 and Antti Lauerma4,5
Chemokine receptor CCR4 is expressed by Th2 cells and is involved in the recruitment of inflammatory cells
into the skin. We studied the effects of CCR4 deficiency in the murine model of oxazolone-induced contact
hypersensitivity in CCR4/ and wild-type (WT) mice. The inflammatory response in the skin at 24 hours
post-elicitation was stronger in CCR4/ mice compared with WT, evidenced by increased ear swelling and
inflammatory cell infiltration. In addition, the mRNA expression levels of several cytokines, chemokines,
chemokine receptors, and selectins in the skin of CCR4/mice were significantly elevated compared with WT
mice. Time kinetic experiments during the sensitization and elicitation phases revealed that the number of
CD3þCD4þ cells in CCR4/ mice remained high longer during the sensitization phase and increased more
rapidly during the elicitation phase compared with WTmice. These data demonstrate that the absence of CCR4
results in enhanced secondary immune response during allergic skin inflammation.
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INTRODUCTION
Contact hypersensitivity (CHS) is an immunological response
against a small chemical hapten. During the sensitization
phase, dermal dendritic cells and Langerhans cells take up
the hapten peptide conjugate and process it and migrate to
the draining lymph node (LN) (Kaplan et al., 2008), where
they present the antigen to naive T cells, leading to the
formation of antigen-specific memory T cells. Subsequent
contact with the same chemical results in the activation of
memory T cells and the recruitment of inflammatory cells to
the site of allergen exposure. This elicitation response is
manifested as skin inflammation, which in a clinical context
is called allergic contact dermatitis (Saint-Mezard et al.,
2004).
The recruitment of inflammatory cells from the circulation
to the site of inflammation is a multifaceted process. It
involves the expression of E-selectin and P-selectin, adhesion
molecules important for tethering and rolling of leukocytes
on the vascular endothelium (Harari et al., 1999) and is
essential for the development of skin inflammation in CHS
(Catalina et al., 1999; Fujita et al., 2007; Alban et al., 2009).
In addition, a chemotactic stimulus on the endothelial cell
surface is required for firm attachment of the leukocytes onto
the endothelial cells and migration into the tissue (Vestweber
and Blanks, 1999).
CCR4 is a chemokine receptor responding to chemokines
CCL17 and CCL22 (Godiska et al., 1997; Imai et al., 1997,
1998) and is expressed by the majority of skin-homing
CD4þ CLAþ cells (Andrew et al., 2001). CCR4 is involved
in antigen-mediated recruitment of CD4 T cells into the skin
and is important in the formation of a mature circulating
cutaneous memory Th-cell population (Andrew et al., 2001;
Reiss et al., 2001; Baekkevold et al., 2005; Campbell et al.,
2007). Although CCR4 cells have traditionally been asso-
ciated with Th2 cells (Imai et al., 1999), Kusumoto et al.
(2007) reported elevated expression of CCR4, CCL17, and
CCL22 in the skin of mice sensitized with oxazolone (OXA),
which is known to induce a Th1-dominated response
(Dearman et al., 1994). Also, it has been observed in various
CHS models that, together with CCR10, CCR4 is an important
receptor for recruiting inflammatory cells to the site of
inflammation (Reiss et al., 2001; Mirshahpanah et al., 2008).
In addition, CCR4 has been shown to be important for
the function of regulatory T cells (Tregs), and more than
80% of human peripheral blood CD25þ T cells express
CCR4 (Iellem et al., 2001, 2003; Baatar et al., 2007; Yuan
et al., 2007). Furthermore, mice that lack CCR4 in their
Tregs develop spontaneous inflammation in the skin (Sather
et al., 2007).
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Because CCR4 is involved in both promoting and
suppressing immune responses, and has a crucial function
in CHS, we studied the effects of OXA sensitization in
CCR4/ mice. Compared with wild-type (WT) mice,
CCR4/ mice mounted a more severe inflammatory
response in the skin.
RESULTS
OXA-treated CCR4/ mice mount more vigorous
inflammation
To study the role of CCR4 in OXA-induced CHS, we
sensitized WT mice and CCR4/ mice with OXA or vehicle
and challenged all the mice 1 week later with OXA on both
ears. At 24 hours post-OXA exposure, the swelling of the ears
was significantly increased in the CCR4/ mice compared
with WT mice (Figure 1a). Histological samples show that the
increase in ear thickness in the knockout mice correlates
well with increased edema and cell infiltration (Figure 1b).
The CCR4/ mice had significantly elevated numbers
of total inflammatory cells and slightly elevated numbers of
lymphocytes, neutrophils, and eosinophils (Figure 1c).
According to immunohistochemical stainings, significantly
more CD4þ cells had infiltrated the skin in CCR4/ mice
compared with WT, although there were no differences in the
number of CD8þ cells (Figure 2a). The ratio of CD4þ /
CD8þ cells in the skin was elevated in CCR4/ mice
compared with WT (Figure 2b), which was confirmed also
with flow cytometric analyses (Figure 2c). The number
of mast cells was similar in both OXA-sensitized groups
(data not shown).
Upregulated mRNA expression of inflammatory mediators in
OXA-treated CCR4/ mice compared with the WT
Next, we compared the mRNA expression levels of inflam-
matory mediators from the ear tissue of the WT and CCR4/
mice. The expression levels of proinflammatory cytokines
such as tumor necrosis factor-a and IL-6 were elevated in
both OXA-treated groups compared with vehicle-treated
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Figure 1. Ear tissue from vehicle (VEH) and oxazolone (OXA)-treated mice 24 hours after OXA elicitation. (a) Ear swelling is significantly increased in
OXA-treated CCR4/ mice compared with wild-type (WT). (b) Hematoxylin–eosin staining of ear tissue from OXA-treated WT and CCR4/ mice
reveals increased edema and inflammatory cell infiltration in CCR4/ mice compared with WT mice. Bar¼100 mm. (c) Number of total inflammatory
cells, lymphocytes, eosinophils, and neutrophils in the ear tissue of VEH-treated and OXA-treated mice. *Po0.05, **Po0.01, ***Po0.001; bars represent
meanþ SEM, n¼8. HPF, high power field.
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Figure 2. CD4þ and CD8þ cells in the skin. (a) According to
immunohistochemical stainings, increased numbers of CD4þ cells have
infiltrated the skin of oxazolone-sensitized and challenged CCR4/ mice
compared with wild-type (WT) mice, although there are no differences in the
number of CD8þ cells. Ratio of CD4þ /CD8þ cells is increased in
CCR4/ mice compared with WT as evidenced by (b) immunohistochemistry
(IHC) stainings and (c) flow cytometric (FC) analysis. *Po0.05; bars represent
meanþ SEM, n¼4–6. HPF, high power field.
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mice, but significantly more in CCR4/ than in WT. Also,
IL-1b expression was slightly elevated in CCR4/ mice
compared with WT (Figure 3a). In addition, mRNA expres-
sion levels of the Th1-type cytokine IL-12p35 and Th2-type
cytokines IL-4 and IL-13 were significantly elevated in OXA-
sensitized CCR4/ mice compared with the WT. The
expression level of IFN-g was only slightly elevated in the
CCR4/ mice (Figure 3b). According to flow cytometric
analysis, similar percentages of T cells in the skin stained
positive for IFN-g and IL-13 in the WT and CCR4/ mice
(Figure 3c); hence, the increased IL-13 mRNA levels
were probably a result of increased numbers of CD3þ
IL-13þ cells.
The increased number of inflammatory cells in the skin
may be a result of more intensive recruitment. IL-1b and
tumor necrosis factor-a are known to induce the expression of
E-selectin and P-selectin (Harari et al., 1999), adhesion
molecules important for the migration of inflammatory cells
into the skin. In our experiment, the mRNA expression of
both these selectins was significantly increased in OXA-
sensitized CCR4/ mice (Figure 4a). In addition, increased
mRNA expression levels of the chemokines CCL3, CCL4,
CCL5, and CCL8 (Figure 4b) and corresponding receptors,
CCR5 and CCR3, were detected in the skin of CCR4/mice
(Figure 4c). Of the CCR4 ligands, CCL17 was significantly
elevated in both OXA-treated groups, whereas CCL22
expression was at similar levels in all groups (Figure 4b).
Immunofluorescence staining revealed CCR4 expression in
the skin of OXA-treated WT mice (Supplementary Figure S1
online), although the relative expression of CCR4 mRNA was
lower in OXA-treated WT mice than in vehicle-treated mice
(Figure 4c).
The CCL27–CCR10 pathway has been shown to compen-
sate for the lack of the CCL17/CCL22-CCR4 pathway in the
recruitment of inflammatory cells to the skin (Reiss et al.,
2001; Mirshahpanah et al., 2008). WT mice and CCR4/
mice both expressed mRNA for CCL27 and CCR10
(Figure 5a). In addition, flow cytometric analysis revealed
similar percentages of CCR10þ cells in both in the WT and
the CCR4/ mice (Figure 5b). T cells from CCR4/ mice
had greatly impaired chemotaxis toward CCR4 ligands
CCL17 and CCL22, but showed similar chemotactic response
toward CCL27 compared with WT T cells (Figure 5c).
Increased numbers of CD3þCD4þ cells in the draining
LNs of CCR4/ mice
To further understand the events that lead to increased
inflammation in CCR4/ mice at 24 hours post-challenge,
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Figure 3. Cytokine expression in the skin. (a) Real-time PCR analysis of ear tissue 24 hours after elicitation with oxazolone. Significantly elevated mRNA
expression of proinflammatory cytokines IL-1b, IL-6, and tumor necrosis factor (TNF)-a in oxazolone (OXA)-treated groups versus vehicle-treated mice. In
addition, IL-6 and TNF-a are significantly more expressed in the CCR4/OXA group compared with the WT (wild-type) OXA group. (b) The mRNA expression
of Th1 (IL-12p35) and Th2 (IL-4, IL-13) cytokines shows a similar pattern to proinflammatory cytokines, n¼ 8. (c) Similar percentages of CD3þ cells express IL-
13 and IFN-g in phorbol myristate acetate and ionomycin-stimulated skin cells from OXA-sensitized and challenged WT and CCR4/ mice, n¼ 3. *Po0.05,
**Po0.01, ***Po0.001; bars represent meanþ SEM. RU, relative units.
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mice were sensitized as before and the numbers of
CD3þCD4þ and CD3þCD8þ cells were determined
0, 2, 4, and 7 days after sensitization as well as 0, 4, 12, and
24 hours post-elicitation. The number of the cells was
calculated by counting the number of total cells in the
draining LN, analyzing with flow cytometry, and multiplying
the cell number by the percentage of CD3þCD4þ or
CD3þCD8þ cells. In the sensitization phase, there were
no differences in the numbers of CD3þCD4þ or
CD3þCD8þ cells, except at 7 days post-sensitization, at
which point the number of CD3þCD4þ cells was down-
regulated in the WT but not in the CCR4/ mice compared
with 4 days after sensitization (Figure 6a). In the elicitation
phase, the number of CD3þCD4þ cells was significantly
elevated at 4 and 12 hours post-elicitation in CCR4/ mice
compared with WT mice (Figure 6b). There was also a slight
increase in the number of CD3þCD8þ cells in CCR4/
mice during the elicitation phase, but this difference was not
statistically significant (Figure 6b). In addition, we analyzed
the ear swelling responses at 2, 4, 6, 12, and 24 hours after
elicitation and observed an increased ear swelling response
as early as 12 hours post-elicitation in the CCR4/ mice,
although the increase was statistically significant only at
24 hours post-challenge (Figure 6c).
Increased number of CD3þ IL-13þ cells in the draining
LNs of CCR4/ mice after elicitation
LN cell suspensions from different time points after elicitation
were prepared, stimulated with phorbol myristate acetate and
ionomycin, and analyzed with flow cytometry. The number
of CD3þ IL-13þ cells was slightly increased in CCR4/
mice throughout the elicitation phase, whereas the number of
CD3þ IFN-gþ cells was comparable at all time points
studied (Figure 7a). The mRNA analysis of stimulated
cells at the 24 hours time point was consistent with these
data, showing a slight increase in IL-13 mRNA expression
in CCR4/ mice and no difference in IFN-g expression
(Figure 7b).
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Figure 4. The mRNA expression analysis of ear tissue. (a) P- and E-selectins, (b) multiple chemokines (CCL3, CCL4, CCL5, CCL8, CCL17, and CCL22),
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Tregs are able to infiltrate the skin of CCR4/ mice
CCR4 has proven to be important for the function of Tregs
and the recruitment of Tregs to the skin and draining LN
(Denning et al., 2005; Baatar et al., 2007; Sather et al., 2007;
Yuan et al., 2007). In our experiment, at 24 hours post-
elicitation, Foxp3 mRNA was significantly increased in the
skin of CCR4/ OXA mice (Figure 8a). This finding was
further confirmed with flow cytometry and immuno-
histochemical stainings (Figure 8b). In the draining LN, the
number of Foxp3þ cells followed the kinetics of
CD3þCD4þ cells in both the WT and the CCR4/ mice
in the sensitization phase as well as in the elicitation phase
(Figure 8c). In the skin, OXA-sensitized CCR4/ mice
expressed at 24 hours significantly more mRNA for the
suppressive cytokine TGF-b, but the expression level of
another important suppressive cytokine, IL-10, was only
slightly elevated in CCR4/ mice (Figure 8a).
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DISCUSSION
Human allergic contact dermatitis shares many features with
murine CHS, and valuable information regarding allergic
contact dermatitis has been collected by studying CHS in
mouse models induced by various chemicals. CCR4 is a
chemokine receptor expressed especially by Th2 cells
(Imai et al., 1999) and is also expressed by CLAþ cells,
having a function in cutaneous inflammation (Andrew et al.,
2001; Iellem et al., 2003). Previous studies have revealed
an important function for CCR4 and corresponding ligands,
CCL17 and CCL22, in CHS (Kusumoto et al., 2007;
Mirshahpanah et al., 2008). To further clarify the role of
CCR4 in CHS, we studied the effects of OXA-induced CHS
in CCR4/ mice.
The absence of CCR4 had a clear effect on the
inflammatory response. CCR4/ mice demonstrated sig-
nificantly elevated ear swelling responses, increased infiltra-
tion of inflammatory cells, and enhanced expression of
inflammatory cytokines and chemokines in the skin com-
pared with WT. In addition, the number of CD3þCD4þ
cells was increased in OXA-treated CCR4/ mice. These
results suggest that CCR4 is involved in the regulation of the
immune response during OXA-induced CHS.
The CCL27–CCR10 pathway has been shown to have
overlapping roles with the CCL17/CCL22-CCR4 pathway in
the cellular recruitment to the skin (Reiss et al., 2001;
Mirshahpanah et al., 2008). In line with these reports, in our
experiment CCR4/ mice expressed mRNA for the skin-
homing receptor CCR10 and had percentages of
CD3þCCR10þ cells that were similar to those for WT
mice (Figure 5a and b), indicating that CCR10-mediated
recruitment of the inflammatory cells is available in CCR4/
mice. Chemotaxis assay, however, suggests that CCR4/
mice do not possess any enhanced migration capacity toward
CCL27 compared with WT mice (Figure 5c), which is also in
accordance with previous studies (Reiss et al., 2001).
In the sensitization phase, the numbers of CD3þCD4þ
and CD3þCD8þ cells in the draining LN followed the same
kinetics in the WT and CCR4/ mice, except at day 7 post-
sensitization, when the number of CD3þCD4þ cells was
downregulated in the WT but was sustained at a similar level
in CCR4/ mice compared with day 4 after sensitization.
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In the elicitation phase, the numbers of CD3þCD4þ cells at
4 and 12 hours post-elicitation were significantly elevated
in CCR4/ mice (Figure 6a and b). These results suggest
that the sustained numbers of CD3þCD4þ cells in the
sensitization phase led to a more rapid increase in the
number of these cells in the secondary phase. In addition, this
increase was followed by elevated amounts of CD3þCD4þ
cells at the site of inflammation at 24 hours post-elicitation,
inducing a shift in the CD4/CD8 balance in the skin of
CCR4/ mice (Figure 2). Moreover, the number of IL-13-
producing CD3þ cells had increased in CCR4/mice after
elicitation (Figure 7a), and a slightly elevated ear swelling
response was observed as early as 12 hours post-elicitation
in the CCR4/mice compared with WT mice (Figure 6c). In
conclusion, these results indicate that the secondary response
to OXA starts earlier and is more dominated by CD4þ cells
in CCR4/ mice, which most likely is the reason for
augmented inflammation seen at the 24 hour time point in
CCR4/ mice compared with WT mice.
Sather et al. (2007) have shown that CCR4 deficiency in
Tregs results in severe leukocyte infiltration and inflammation
in the skin. They observed impaired homing of CCR4-
deficient Tregs to the skin and concluded that this would be
the reason for spontaneous inflammation seen in the skin of
mice that lack CCR4 in their Tregs. In our experiment, the
mRNA levels of Foxp3 were significantly elevated in the skin
of CCR4/ mice compared with the WT, indicating that
CCR4/ Tregs were able to migrate into the skin. This
finding was confirmed with flow cytometry and immunohis-
tochemistry stainings (Figure 8a and b). These results suggest
that during homeostasis CCR4 is important for homing of
Tregs to the skin, but that during an inflammatory response
Tregs are able to accumulate in the skin even in the absence
of CCR4. Flow cytometric analysis revealed that approxi-
mately 10% of the Tregs from LNs of OXA-sensitized mice
expressed CCR10 (Supplementary Figure S2 online), which
most likely means that CCR10 can compensate for the lack of
CCR4 also in Tregs. We also studied the number of Tregs in
the draining LNs at different time points after sensitization
and elicitation and noticed that the numbers of
FoxpþCD3þ cells followed the kinetics of CD3þCD4þ
T-cell expansion in both the WT and the CCR4/ mice.
These results indicate that Tregs are able to infiltrate the skin
and draining LN in spite of CCR4 deficiency and that they
also proliferate at similar rates in the WT and CCR4/mice.
However, we cannot rule out the possibility that the function
of Tregs is impaired in CCR4/ mice. Tregs use multiple
mechanisms to suppress inflammation. In our experiment, the
mRNA expression level of TGF-b, which has been shown to
be important in Treg-mediated suppression in several in vivo
models (Vignali et al., 2008), was also significantly increased
in the skin of CCR4/ mice. In contrast, IL-10, an important
suppressive cytokine produced by Tregs during CHS
(Ring et al., 2006; Cavani, 2008), was elevated only slightly
in CCR4/ mice compared with WT. However, both these
cytokines are produced by many cell types, and no
conclusions about the functionality of Tregs can be made
on the basis of these mRNA data.
In conclusion, CCR4 has a function in the control of
inflammation in the skin, as the absence of CCR4 exacerbates
the inflammation. In the future, more studies are needed to
fully understand the effects of CCR4 during inflammation at
both the systemic and the tissue-specific levels. In addition,
manipulation of chemokine responses—for example, with
biological drugs such as recently discovered evasins (Deruaz
et al., 2008)—at both the sensitization and the elicitation
phases may help us to find new ways to induce tolerance to
selected haptens.
MATERIALS AND METHODS
Mice and sensitization protocol
Heterozygous B6;129P-Ccr4tm1Pwr mice were purchased from The
Jackson Laboratory (Bar Harbor, ME) kept in pathogen-free condi-
tions in the animal facilities of the Finnish Institute of Occupational
Health, bred, and genotyped. All the procedures concerning animals
were accepted by Social and Health Services of the State Provincial
Office of Southern Finland.
Seven-week-old littermates homozygous for the WT allele or
deleted CCR4 allele were selected for the sensitization protocol,
which was carried out as previously described, with a few
modifications (Lauerma et al., 1995). Briefly, 50 ml of OXA
(10mgml1) or vehicle (acetone/olive oil, 4:1) was pipetted
onto the shaved and tape-stripped skin. One week later, mice
were anesthetized, ear swelling was measured, and 25 ml of OXA
(3mgml1) was pipetted onto the dorsal side of both ears. After
24 hours the mice were killed, ear thickness was measured, and
samples were collected. For kinetic experiments, mice were
sensitized with OXA as described above. The mice were killed
and samples collected 0, 2, 4, or 7 days after sensitization and 0, 4,
12, or 24 hours after elicitation. Ear swelling was measured at 0, 2, 4,
6, 12, and 24 hours after elicitation.
Real-time PCR
Ears were homogenized in Trizol (Invitrogen, Camarillo, CA), and
RNA was extracted according to standard protocols and subjected to
complementary DNA synthesis. Real-time quantitative PCR was
performed using commercial or self-designed primers and probes
with an ABI PRISM 7700 Sequence Detector (Applied Biosystems,
Foster City, CA). Commercial primers and probes for ribosomal 18S
(Applied Biosystems) were used as an endogenous control to ensure
an equal amount of RNA in each sample. Self-designed primer
sequences and the formula for calculating relative units are given in
the Supplementary Materials and Methods online.
Histological stainings
Part of the ear was fixed in 10% formalin and embedded in paraffin.
Multiple 4-mm-thick sections were stained with hematoxylin–eosin
or toluidine blue.
Immunohistochemical and immunofluorescence stainings
Four-mm-thick frozen sections were fixed with acetone and stained
with monoclonal anti-CD4, anti-CD8 (BD Biosciences, San Jose,
CA), or anti-Foxp3 (eBiosciences, San Diego, CA). For immuno-
fluorescent staining of CCR4, frozen sections were stained with goat
polyclonal anti-CCR4 (Abcam, Cambridge, UK) and Alexa Fluor 568
rabbit anti-goat IgG (Hþ L) secondary antibody (Invitrogen).
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Single-cell suspension preparation from skin and flow
cytometric analysis
A piece of inflamed ear skin was cut into very small pieces, crushed
through a 70-mm cell strainer (BD Biosciences), washed with
phosphate-buffered saline, and filtered again through a 40-mm cell
strainer (BD Biosciences). Unstimulated cells were surface stained with
Alexa Fluor 488-conjugated anti-CD3, PerCP-Cy5-conjugated anti-
CD4, and Alexa Fluor 700-conjugated anti-CD8 (eBiosciences). After
surface stainings, cells were fixed and permeabilized for intracellular
phycoerythrin-conjugated Foxp3 staining using a commercial Foxp3
staining kit according to the manufacturer’s instructions (eBiosciences).
CCR10 was stained using anti-CCR10 (Capralogics, Hardwick, MA)
and a secondary phycoerythrin-conjugated anti-goat antibody (R&D
Systems, Minneapolis, MN). For intracellular cytokine analysis, cells
were stimulated with phorbol myristate acetate (20ngml1) and
ionomycin (1mgml1) in the presence of Brefeldin A (10mgml1)
for 5hours, after which the cells were washed, surface stained
as above, fixed, and permeabilized for intracellular staining of
phycoerythrin-conjugated anti-IL-13 and allophycocyanin-conjugated
IFN-g (eBiosciences) using a Fix and Perm kit from Caltag (Burlingame,
CA) as instructed by the manufacturer. Samples were analyzed with
FacsCantoII (BD Biosciences) using FACS Diva software, and the data
were analyzed using FlowJo software.
LN preparations
For kinetic studies, cells from axillar LNs (after sensitization) or
cervical LNs (after elicitation) were isolated by crushing the LNs,
filtering through a 100-mm filter, and washing with phosphate-
buffered saline. The number of cells was calculated, and a million
cells were stained directly for CD3, CD4, CD8, and Foxp3
expression, in a way similar to that used for the skin samples. For
intracellular stainings, cells were stimulated and stained as described
for the skin samples. At the 24 hour time point, a sample
of stimulated cells was also lysed in Trizol (Invitrogen), and RNA
was isolated as mentioned above and subjected to complementary
DNA synthesis and subsequent real-time-PCR analysis.
Chemotaxis assay
For the chemotaxis assay, cells were isolated from the draining LNs of
sensitized mice and enriched for CD4þ T cells using a mouse CD4þ
T-cell enrichment kit according to the manufacturer’s instructions
(Stem Cell Technologies, Vancouver, BC, Canada). After enrichment,
cells were suspended in complete RPMI 1640 with 1% BSA. Each
chemokine, CCL17, CCL22, or CCL27 (R&D Systems), was added at a
concentration of 100nM to the feeder well (Costar Transwell, Corning,
NY) and 1 million cells were added to the insert with a 5-mm pore size.
Chemotaxis was allowed to proceed for 3.5 hours, after which the
number of migrated cells was counted and the chemotactic index was
calculated by dividing the number of migrated cells by the number of
cells that had migrated into the medium alone.
Statistical analysis
Statistical analyses were carried out with Student’s t-test or the
nonparametric Mann–Whitney U-test using GraphPad Prism software
(GraphPad Software, La Jolla, CA).
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